Clinical Trials Browser

Phase 1/2 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × idelalisib × Clear all

NCT03742323 2021-09-05

REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia

Phase 1/2 Terminated

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma